1PRZEPIORKA D,KEMAN N A,IPPOLITI C,et al.Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft - versus - host disease[].Blood.2000
2NADEMANEE A,SCHMIDT G M,PARKER P,et al.The outcome of matched unrelated donor bone marrow transplantation in patients with hematological malignancies using molecular typing for donor selection and graft-versus-host-disease prophylaxis regimen of cyclosporine, methotrexate and prednisone[].Blood.1995
3BASARA N,BLAU W I,ROMER E,et al.Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplantation patients[].Bone Marrow Transplantation.1998
4NASH R A,PINCIRO L A,STORB R,et al.FK506 in combination with methofrexate for the prevention of graft-versus-host-disease after bone marrow transplantation from matched unrelated donors[].Blood.1996
5HEBART H,EHNINGER G,SCHMIDT H,et al.Treatment of steroid- resistant graft - versus - host disease after allogenetic bone marrow transplantation with anti - CD3 /TCR monoclonal antibodies[].Bone Marrow Transplantation.1995
6PATEL P M,SELBY P J,GRAHAM M A,et al.Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies[].Hematological Oncology.1993
7BACIGALUPO A,BROCCIA G,CORDA G,et al.Antilymphocyte globulin, cyclosporine, and granulocyte colony - stimulating factor in patients with acquired severe aplastic anemia: apilot study of the EBMT SAA Working Party[].Blood.1995
8OSMAN I,KOC H,ISMET A,et al.Combined immunosupressive therapy in a plastic anemia[].Indian Journal of Medical Research.1995
